Work

It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)

Year: 2013
Type: editorial
Abstract: Rapamycin might have beneficial effects, some of them acting via autophagy, in several cellular, fly and mouse models of degenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and dominant spinocerebellar atrophy (SCA). Other more sophisticated mechanisms have been described such as intervention in cell signaling and cell transcription particularly related to PD. Yet AD, PD, HD and SCA3 are chronic degenerative diseases, and chronic administration of rapamycin at advanced clinical stages may result in deleterious systemic effects due to chronic inhibition of mammalian target of rapamycin (mTOR). Studies are needed to uncover more specific inhibitors of particular mTOR signaling pathways, and to establish realistic guidelines for treatment at early stages of neurodegenerative processes.
Language: English
Subfield: Cell Biology
Open Access status: bronze
OpenAlex ID: W2126232574
Cites: 17
Cited by: 17
Related to: 10